CING Cingulate
- 1.1307
- +0.0907+8.72%
Cingulate News
Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board Member, to Be Featured With Chairman and CEO Shane J. Schaffer on Benzinga All Live Access
KANSAS CITY, Kan., April 30, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release (PTR) drug delivery platform technology
Cingulate to Participate in Planet MicroCap Showcase: Vegas 2024
KANSAS CITY, Kan., April 16, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release (PTR) drug delivery platform technology
Cingulate Inc (CING) Receives a Hold From Maxim Group
Cingulate Reports Q4 Results
Cingulate Had $52,416 in Cash and Cash Equivalent at Dec 31 >CINGW
Cingulate Had $52,416 in Cash and Cash Equivalent at Dec 31 >CINGW
Cingulate 4Q Loss $6.93M >CINGW
Cingulate 4Q Loss $6.93M >CINGW
Cingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update
Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced its financial results for the twelve months ended December 31, 2023, and provided a clinical and business update.
Cingulate to Participate in Benzinga All Live Access Event
Cingulate to Attend DCAT Week 2024 in New York City
KANSAS CITY, Kan., March 06, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release (PTR) drug delivery platform technology
Cingulate Inc Bolsters Board, Targets Nasdaq Compliance
Cingulate Expands Board With New Directors Amid Financial Activity Surge
Press Release: Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to Its Board of Directors
Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors Announcement Follows Recent Public Offering and Successful Capital Raising Activity KANSAS CITY, Kan., Feb. 1
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersThermoGenesis Holdings (NASDAQ:THMO) stock moved upwards by 39.0% to $0.86 during Wednesday's regular session. The market value of their outstanding shares is at $2.7 million. Femasys (NASDAQ:F
Cingulate Announces Closing of $7.5 Million Public Offering
KANSAS CITY, Kan., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING) ("Cingulate," the "Company," "we," "our" or "us"), a biopharmaceutical company utilizing its proprietary Precision Timed Release
U.S. Shares Higher at Close of Trade; Dow Jones Industrial Average up 0.35%
Top Midday Decliners
Cingulate (CING) shares plummeted Friday after the company said it priced a public offering of 3.75 million shares, series A warrants to buy up to 3.75 million shares and series B warrants to buy up t
KOPN, CAMP and FGEN Among Mid-day Movers
12 Health Care Stocks Moving In Friday's Intraday Session
GainersIntelligent Bio Solutions (NASDAQ:INBS) shares rose 108.5% to $5.03 during Friday's regular session. The company's market cap stands at $3.6 million. Atara Biotherapeutics (NASDAQ:ATRA) stock i
Express News | Cingulate Shares Are Trading Lower After the Company Announced Pricing of a $7.5 Million Public Offering
Nasdaq Rises Over 200 Points; Apple Posts Upbeat Earnings
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 200 points on Friday. The Dow traded up 0.19% to 38,593.49 while the NASDAQ rose 1.55% to 15,600.39. The S&P 50
Analysis
Price Target
No Data
